Interferon regulatory factors in human lupus pathogenesis

Hooks, 1979, Immune interferon in the circulation of patients with autoimmune disease, N Engl J Med, 301, 5, 10.1056/NEJM197907053010102

Pestka, 2004, Interferons, interferon-like cytokines, and their receptors, Immunol Rev, 202, 8, 10.1111/j.0105-2896.2004.00204.x

Niewold, 2010, Interferon alpha in systemic lupus erythematosus, J Biomed Biotechnol, 2010, 948364, 10.1155/2010/948364

Crow, 2003, Microarray analysis of interferon-regulated genes in SLE, Autoimmunity, 36, 481, 10.1080/08916930310001625952

Baechler, 2003, Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus, Proc Natl Acad Sci U S A, 100, 2610, 10.1073/pnas.0337679100

Ronnblom, 1990, Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour, J Intern Med, 227, 207, 10.1111/j.1365-2796.1990.tb00144.x

Niewold, 2005, Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C, Clin Rheumatol, 24, 178, 10.1007/s10067-004-1024-2

Niewold, 2008, Interferon alpha-induced lupus: proof of principle, J Clin Rheumatol, 14, 131, 10.1097/RHU.0b013e318177627d

Niewold, 2007, High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus, Genes Immun, 8, 492, 10.1038/sj.gene.6364408

Niewold, 2008, Age- and sex-related patterns of serum interferon-alpha activity in lupus families, Arthritis Rheum, 58, 2113, 10.1002/art.23619

Kariuki, 2010, Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus, Arthritis Res Ther, 12, R151, 10.1186/ar3101

Kariuki, 2008, The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus, Arthritis Rheum, 58, 2818, 10.1002/art.23728

Kariuki, 2009, Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus, Genes Immun, 10, 487, 10.1038/gene.2009.15

Kariuki, 2010, Genetic regulation of serum cytokines in systemic lupus erythematosus, Transl Res, 155, 109, 10.1016/j.trsl.2009.08.012

Kariuki, 2009, Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo, J Immunol, 182, 34, 10.4049/jimmunol.182.1.34

Weckerle, 2011, Network analysis of associations between serum interferon alpha activity, autoantibodies, and clinical features in systemic lupus erythematosus, Arthritis Rheum, 10.1002/art.30187

Kariuki, 2010, Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients, J Biomed Biotechnol, 2010, 826434, 10.1155/2010/826434

Lodolce, 2010, African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity, J Immunol, 184, 7001, 10.4049/jimmunol.1000324

Salloum, 2010, Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients, Arthritis Rheum, 62, 553, 10.1002/art.27182

Pothlichet, 2011, A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients, EMBO Mol Med, 10.1002/emmm.201000120

Graham, 2006, A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus, Nat Genet, 38, 550, 10.1038/ng1782

Harley, 2008, Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci, Nat Genet, 40, 204, 10.1038/ng.81

Niewold, 2008, Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients, Arthritis Rheum, 58, 2481, 10.1002/art.23613

Rullo, 2010, Association of IRF5 polymorphisms with activation of the interferon alpha pathway, Ann Rheum Dis, 69, 611, 10.1136/ard.2009.118315

Feng, 2010, Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus, Arthritis Rheum, 62, 562, 10.1002/art.27223

Chang, 2010, Important aspects of Toll-like receptors, ligands and their signaling pathways, Inflamm Res, 59, 791, 10.1007/s00011-010-0208-2

Lovgren, 2004, Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG, Arthritis Rheum, 50, 1861, 10.1002/art.20254

Lovgren, 2006, Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren’s syndrome autoantigen-associated RNA, Arthritis Rheum, 54, 1917, 10.1002/art.21893

Kariuki, 2008, The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus, Arthritis Rheum, 58, 2818, 10.1002/art.23728

Paun, 2007, The IRF family, revisited, Biochimie, 89, 744, 10.1016/j.biochi.2007.01.014

Tamura, 2008, The IRF family transcription factors in immunity and oncogenesis, Annu Rev Immunol, 26, 535, 10.1146/annurev.immunol.26.021607.090400

Battistini, 2009, Interferon regulatory factors in hematopoietic cell differentiation and immune regulation, J Interferon Cytokine Res, 29, 765, 10.1089/jir.2009.0030

Wang, 2009, IRF8 regulates myeloid and B lymphoid lineage diversification, Immunol Res, 43, 109, 10.1007/s12026-008-8055-8

Shaffer, 2008, IRF4 addiction in multiple myeloma, Nature, 454, 226, 10.1038/nature07064

Graham, 2007, Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus, Proc Natl Acad Sci U S A, 104, 6758, 10.1073/pnas.0701266104

Gateva, 2009, A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus, Nat Genet, 41, 1228, 10.1038/ng.468

Tsujimura, 2004, Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells, J Immunol, 172, 6820, 10.4049/jimmunol.172.11.6820

Barnes, 2003, Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death, Cancer Res, 63, 6424

Barnes, 2001, Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes, J Biol Chem, 276, 23382, 10.1074/jbc.M101216200

Reddy, 2007, Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans, Hum Genet, 121, 721, 10.1007/s00439-007-0367-6

Shin, 2008, Different genetic effects of interferon regulatory factor 5 (IRF5) polymorphisms on systemic lupus erythematosus in a Korean population, J Rheumatol, 35, 2148, 10.3899/jrheum.080124

Kawasaki, 2008, Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms, Arthritis Rheum, 58, 826, 10.1002/art.23216

Kelly, 2008, Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans, Genes Immun, 9, 187, 10.1038/gene.2008.4

Siu, 2008, Association of a haplotype of IRF5 gene with systemic lupus erythematosus in Chinese, J Rheumatol, 35, 360

Sigurdsson, 2008, Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus, Hum Mol Genet, 17, 872, 10.1093/hmg/ddm359

Wen, 2010, Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function, Autoimmunity

Richez, 2010, IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus, J Immunol, 184, 796, 10.4049/jimmunol.0901748

Zhang, 2002, Structure and function of IRF-7, J Interferon Cytokine Res, 22, 95, 10.1089/107999002753452700

De Jager, 2009, Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci, Nat Genet, 41, 776, 10.1038/ng.401

Javed, 2006, Therapeutic role of beta-interferons in multiple sclerosis, Pharmacol Ther, 110, 35, 10.1016/j.pharmthera.2005.08.011

Weckerle, 2011, The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies, Clin Rev Allergy Immunol, 40, 42, 10.1007/s12016-009-8192-4

Poole, 2006, Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus, Autoimmunity, 39, 63, 10.1080/08916930500484849

Lenert, 2010, Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus, Clin Exp Immunol, 161, 208, 10.1111/j.1365-2249.2010.04176.x

Yao, 2009, Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus, Arthritis Rheum, 60, 1785, 10.1002/art.24557